Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Pediatr Blood Cancer. 2021 Aug 2;68(10):e29257. doi: 10.1002/pbc.29257

Table 2.

PROMIS-25 Pediatric Health-related Quality of Life domain scores and Pain Intensity throughout pediatric lymphoma treatment in Lilongwe, Malawi.

Diagnosis Treatment Follow-Up
N = 75 N = 35 N = 24
Days since Diagnosis, median [IQR] 0 [0–0] 113 [61–210] 720 [486–1014]
Patient Reported, n (%) 57 (76) 27 (77) 16 (67)
Caregiver Reported, n (%) 18 (14) 8 (13) 8 (33)
PROMIS HRQoL Domains Mean score (SD) Mean score (SD) Δ** Mean score (SD) Δ** p-value
Mobility 31.5 (9.1) 49.8 (9.2) −18.3 55.1 (5.6) −5.3 <0.001
Anxiety 61.9 (9.8) 44.1 (10.4) 17.8 41.7 (10.8) 2.4 <0.001
Depressive Symptoms 62.2 (6.7) 46.7 (7.9) 15.5 42.6 (8.5) 4.1 <0.001
Fatigue 61.7 (9.2) 45.9 (8.3) 15.8 42.6 (10.1) 3.3 <0.001
Peer Relationships 49.3 (7.3) 52.6 (9.2) −3.3 60.1 (3.9) −7.5 <0.001
Pain Interference 59.6 (9.5) 47.2 (9.8) 12.4 41.9 (8.9) 5.3 <0.001
Pain Intensity, median [IQR] 9 [4–10] 1 [1–1] 0 [0–0] <0.001
*

Higher PROMIS scores for Mobility and Peer Relationships reflect better functioning and relationships; lower symptom scores reflect better symptom experiences.

**

Δ= Difference in mean domain score between timepoints. Minimally Important Difference (MID) is 2–3 points.33

PROMIS = Patient-Reported Outcomes Measurement Information System; HRQoL= Health-related quality of life, IQR = Interquartile range; SD = Standard Deviation.